[ad_1] STATEN ISLAND, N.Y., Nov. 20, 2024 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“we” or “Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the […]
Tag: Medical Pharmaceuticals
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
[ad_1] Ampersand’s AND™ Platform will be used to identify programmed biologics for the treatment of obesity-related targets Montai’s CONECTA™ AI platform will be used to identify small molecules directed to a potential Non-Small Cell Lung Cancer-related […]
Nagase Viita lanzará el excipiente farmacéutico inyectable «SUCROSE SG» en 2025
[ad_1] OKAYAMA, Japón, 20 de noviembre de 2024 /PRNewswire/ — Nagase Viita Co., Ltd., miembro del Grupo NAGASE con sede en Okayama (Japón), se dispone a ampliar la línea de SOLBIOTE (TM), excipientes farmacéuticos a […]
AmacaThera Announces Phase 1 Results of First-in-Human Study with AMT-143, Exceeding Expectations and Paving the Way for a Novel Approach to Post-Operative Pain Relief USA – English USA – English
[ad_1] TORONTO, Nov. 20, 2024 /PRNewswire/ — AmacaThera today announced results from its Phase 1 clinical trial of AMT-143, an innovative, non-opioid anesthetic, formulated with the company’s patented AmacaGel™ platform, demonstrating sustained anesthetic release out […]
FDA Roundup: November 19, 2024
[ad_1] SILVER SPRING, Md., Nov. 19, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a request for information […]
